{"data":{"id":"us-ne/neb.-rev.-stat.-71-9603","jurisdiction":"us-ne","citation":"Neb. Rev. Stat. § 71-9603","heading":"Eligible patient.","body":"To be an eligible patient under the Investigational Drug Use Act, a person shall:\n(1) Have an advanced illness, attested by the person's treating physician;\n(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;\n(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;\n(4) Give written, informed consent for the use of the investigational drug, biological product, or device;\n(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and\n(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.","path":["Chapter 71 - PUBLIC HEALTH AND WELFARE"],"source_url":"https://nebraskalegislature.gov/laws/statutes.php?statute=71-9603","current_through":"Laws 2026","vintage":"","retrieved_at":"2026-10-18T06:03:47Z","sha256":"bb6781cad36c2ed890f7a372ee7f7c975c2b9a00a71b23f787787202a2691d9b","source_id":"us-ne","stale":false,"prev":"us-ne/neb.-rev.-stat.-71-9602","next":"us-ne/neb.-rev.-stat.-71-9604"},"notice":"GroundRules: Original legal text. Not legal advice."}